Australian Capital Territory Numbered Regulations

DRUGS OF DEPENDENCE REGULATIONS (NO. 14 OF 1993) - SCHEDULE 2

    SCHEDULE 2     Regulations 5 and 6

PROHIBITED SUBSTANCES

Column 1	Column 2	Column 3
Substance	Traffickable quantity (grams)	Commercial quantity (kilograms)

Acetorphine         2.00     2.00
Acetyl-α-methylfentanyl         0.005     0.005
Alkoxyamphetamines and bromo-substituted alkoxyamphetamines, except where separately specified in this Schedule         0.50     0.50
Alkoxyphenethylamines and alkyl-substituted alkoxyphenethylamines, except where separately specified in this Schedule         0.50     0.50
2-Amino-1-(2,5-dimethoxy-4-methyl) phenylpropane (STP, DOM)         0.50     0.50
4-Bromo-3,5-dimethoxyamphetamine         0.50     0.50
4-Bromo-2,5-dimethoxyphenethylamine (BDMPEA)         0.50     0.50
3-Bromo-4-methoxyamphetamine         0.50     0.50
4-Bromo-3-methoxyamphetamine         0.50     0.50
Bufotenine         2.00     2.00
Cannabis         100.00     100.00
Cannabis Oil         2.00     2.00
Cannabis Resin         20.00     50.00
Cathinone         2.00     2.00
Desomorphine         2.00     2.00
N,N-Diethyltryptamine (DET)         2.00     2.00
2,4-Dimethoxyamphetamine         0.50     0.50
3,4-Dimethoxyamphetamine         0.50     0.50
2,5-Dimethoxy-4-bromoamphetamine (DOB)         0.50     0.50
3,4-Dimethoxy-5-ethoxyamphetamine         0.50     0.50
2,5-Dimethoxy-4-ethoxyamphetamine         0.50     0.50
4,5-Dimethoxy-2-ethoxyamphetamine         0.50     0.50
2,5-Dimethoxy-4-ethyl-α-methylphenylethylamine
(DOET)         0.50     0.50
2,3-Dimethoxy-4,5-methylenedioxyamphetamine         0.50     0.50
2,5-Dimethoxy-3,4-methylenedioxyamphetamine         0.50     0.50
2,5-Dimethoxy-α-methylphenylethylamine (DMA)         0.50     0.50
3,4-Dimethoxyphenylethylamine         0.50     0.50
3-(2-Dimethylaminoethyl)-4-hydroxyindole (Psilocine, Psilotsin)         2.00     2.00
3-(1,2-Dimethylheptyl)-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran (DMHP)         2.00     2.00
N,N,-Dimethyltryptamine (DMT)         2.00     2.00
4,5-Ethylenedioxy-3-methoxyamphetamine         0.50     0.50
Eticyclidine (PCE)         2.00     2.00
Etorphine         5.00     2.00
Harmaline         2.00     2.00
Harmine         2.00     2.00
Heroin         2.00     1.50
3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl- 6H-dibenzo[b,d]pyran (Parahexyl)         2.00     2.00
β -Hydroxyfentanyl         0.005     0.005
β -Hydroxy-3-methylfentanyl         0.005     0.005
Ketobemidone         2.00     2.00
Lysergic Acid         0.002     0.002
Lysergide (LSD, LSD-25)         0.002     0.002
Mescaline- see 3,4,5-Trimethoxyphenethylamine
Methaqualone         50.00     50.00
2-Methoxy-3, 4-methylenedioxyamphetamine         50.00     50.00
2-Methoxy-4, 5-methylenedioxyamphetamine         0.50     0.50
4-Methoxy-2, 3-methylenedioxyamphetamine         0.50     0.50
5-Methoxy-3, 4-methylenedioxy-α-methylphenylethylamine (MMDA)         0.50     0.50
2-Methoxy-3, 4-methylenedioxyphenylethylamine         0.50     0.50
3-Methoxy-4, 5-methylenedioxyphenylethylamine         0.50     0.50
4-Methoxy-α-methylphenylethylamine (PMA)         0.50     0.50
4-Methoxyphenylethylamine         0.50     0.50
4-Methylaminorex         2.00     2.00
3, 4-Methylenedioxyamphetamine (MDA)         0.50     0.50
3, 4-Methylenedioxy-N, α-dimethylphenylethylamine (MDMA)         0.50     0.50
3, 4-Methylenedioxy-N-ethylamphetamine (MDE)         0.50     0.50
3-Methylfentanyl         0.005     0.005
α-Methylfentanyl         0.005     0.005
1-Methyl-4-phenyl-4-piperidinol propionate (MPPP)         2.00     2.00
3-Methylthiofentanyl         0.005     0.005
α-Methylthiofentanyl         0.005     0.005
Muscimol         2.00     2.00
Para-fluorofentanyl         0.005     0.005
Phencyclidine (PCP)         2.00     2.00
1-Phenylethyl-4-phenyl-4-piperidinol acetate (PEPAP)         2.00     2.00
Psilocine— see 3-(2-Dimethylaminoethyl)-4-hydroxyindole
Psilocybine         2.00     2.00
Psilotsin— see 3-(2-Dimethylaminoethyl)-4-hydroxyindole
Rolicyclidine (PHP, PCPY)         2.00     2.00
Tenocyclidine (TCP)         2.00     2.00
Tetrahydrocannabinols (THC) and their alkyl homologues, except where separately specified in this Schedule         2.00     5.00
2, 3, 4, 5-Tetramethoxyamphetamine         0.50     0.50
Thiofentanyl         0.005     0.005
2, 3, 4-Trimethoxyamphetamine         0.50     0.50
2, 3, 5-Trimethoxyamphetamine         0.50     0.50
2, 3, 6-Trimethoxyamphetamine         0.50     0.50
2, 4, 5-Trimethoxyamphetamine         0.50     0.50
2, 4, 6-Trimethoxyamphetamine         0.50     0.50
3, 4, 5-Trimethoxy-α-methylphenylethylamine (TMA)         0.50     0.50
3, 4, 5-Trimethoxyphenethylamine (mescaline) and other substances structurally derived from methoxy-phenylethylamine, except—
(a)     methoxyphenamine; or
(b)     where separately specified in this Schedule         7.50     7.50
1-(3, 4, 5-Trimethoxyphenyl)-2-aminobutane         0.50     0.50
2, 4, 5-Trimethoxyphenylethylamine         0.50     0.50
A substance which is, in relation to a prohibited substance specified elsewhere in this Schedule—
(a)     an active principle of that prohibited substance;
(b)     a preparation or admixture of that prohibited substance; or
(c)     a salt of that prohibited substance or active principle;
except where the first-mentioned substance is separately specified in this Schedule         The minimum traffickable quantity
and the minimum commercial quantity, respectively, of—
(a)     the prohibited substance in relation to which the substance is specified in this item; or
(b)     if there is more than 1 such prohibited substance—the prohibited substance referred to in paragraph (a) in relation to which the minimum traffickable quantity and the minimum commercial quantity are respectively the least.
A substance (“drug analogue”) which is, in relation to another substance (being a drug of dependence or a substance specified elsewhere in this Schedule, or a stereoisomer, a structural isomer (with the same constituent groups) or an alkaloid of such a drug or substance)—
(a)     a stereoisomer;
(b)     a structural isomer having the same constituent groups;
(c)     an alkaloid;
(d)     a structural modification notionally obtained in 1 or more of the following ways:
              (i)     by the replacement of up to 2 carbocyclic or heterocyclic ring structures with different carbocyclic or heterocyclic ring structures;
              (ii)     by the addition of hydrogen atoms to 1 or more unsaturated bonds;
              (iii)     by the addition of 1 or more of the following groups, namely alkoxy, cyclic diether, acyl, acyloxy, mono-amino and dialkylamino groups with up to 6 carbon atoms in any alkyl residue; alkyl, alkenyl and alkynyl groups with up to 6 carbon atoms in the group, where the group is attached to oxygen (for example, an ester or an ether group), nitrogen, sulphur or carbon; and halogen, hydroxy, nitro and amino groups;
              (iv)     by the replacement of 1 or more of the groups specified in subparagraph (iii) with another such group or groups;
              (v)     by the conversion of a carboxyl or an ester group into an amide group; or
(e)     otherwise an homologue, analogue, chemical derivative or substance substantially similar in chemical structure;
however manufactured or actually obtained, except where the drug analogue—
(f)     is a drug of dependence;
(g)     is separately specified in this Schedule;
(h)     is specified in a Schedule to the Poisons and Drugs Act 1978 ; or
(i)     is specified in the Schedule to the Public Health (Prohibited Drugs) Act 1957         The minimum traffickable quantity
and the minimum commercial quantity, respectively, of—
(a)     the drug of dependence or prohibited substance in relation to which the substance is a drug analogue; or
(b)     if there is more than 1 such drug or prohibited substance—the drug or prohibited substance referred to in paragraph (a) in relation to which the minimum traffickable quantity and the minimum commercial quantity are respectively the least.